Overall rank by patents
#47,743
Across all tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 6 technology areas, active 2023–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C30B (SINGLE-CRYSTAL GROWTH ; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL ; PRODUCTION OF A HOMOGENEOUS POLYCRYS).
The verdict
Ivworks holds 5 US patents across 6 technology areas, rank #47,743 of 50,000 tracked assignees.
Ivworks Co., Ltd. has been granted 5 US utility patents between 2023 and 2025, placing Ivworks Co., Ltd. at rank #47,743 across all assignees tracked by PlainPatent. This portfolio spans 6 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.0 claims per patent with primary concentration in C30B (SINGLE-CRYSTAL GROWTH ; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL ; PRODUCTION OF A HOMOGENEOUS POLYCRYS). As a Foreign Corporation, Ivworks Co., Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Ivworks sits between IVAX International B.v. (5 patents, rank #47,739) and Ice Adaptive Tires, Llc (5 patents, rank #47,747) - the closest US assignees by grant volume. The composite Innovation Score of 43.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2023 through 2025, with 5 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Ivworks Co., Ltd.'s 15.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 6 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Ivworks Co., Ltd. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
IVAX INTERNATIONAL B.V.
5 patents
IVECO DEFENCE VEHICLES S.P.A.
5 patents
IVERIC bio, Inc.
5 patents
IVSC IP LLC
5 patents
IWASAKI INDUSTRY INC.
5 patents
IWK Verpackungstechnik GmbH
5 patents
IYM Technologies LLC
5 patents
Ice Adaptive Tires, LLC
5 patents
IVWORKS CO., LTD.
5 patents
What this shows Ivworks holds 5 patents at rank #47,743, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #47,743 in granted patent volume.
Other assignees with the most granted patents in Ivworks's primary technology class.
Ivworks's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
44 Top 27% higher than 73% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2023 | 1 | 20.0% |
| 2024 | 3 | 60.0% |
| 2025 | 1 | 20.0% |
Top 6 of 6 technology areas
Overall rank by patents
#47,743
Across all tracked assignees
43.9 out of 100
How to use this portfolio
Ivworks's 5 grants land it in the top 27% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.